Member Info for Richob

It also demonstrates a belief by Avacta that the future benefits of the joint venture outweigh taking cash now.

I wouldn't personally rule Daewoong out of any possible future bidding war either.

Onwards Avacta.

Think this is a "trend and reverse" order but could be talking rubbish as I have no idea how you do one and also thought they were fat finger trades.

We seem to get quite a few on here.

Onwards Avacta.

Looks like there were 24,000 attendees in 2020.

Quite big then.

Onwards Avacta.

Looks like members of the AACR attend this annual conference.

Members include laboratory, translational, and clinical researchers; other health care professionals; and cancer advocates. Membership includes 289 Fellows of the AACR Academy; 56 are Nobel laureates.

No doubt large pharmas have a few researchers amongst their personnel.

Onwards Avacta.

...and T shirts, PL.

Cheers, Timster.

Since last time I checked, Manchester and Glasgow have started recruitment.

https://clinicaltrials.gov/ct2/show/NCT04969835#contactlocation

Onwards Avacta.

I think so. It makes it 4 out of 6 in the UK by the looks of it.

Can't see that there would be additional patient recruitment if it wasn't working.

Onwards Avacta.

Apologies if already posted.

Onwards Avacta

NR11,

I believe it means that they know that taking it forward themselves indicates the likely success financially.

Happy to be corrected.

Onwards Avacta.

Massive statement with regard to current progress of AVA6000.

Onwards Avacta.

I reckon Dr Goldberg played a part in obtaining our slot:

https://www.yorkshirepost.co.uk/business/avacta-announces-appointment-of-new-non-executive-director-3350226

Onwards Avacta.

Who else might it be?

Onwards Avacta.

Gadgie,

Not sure that "Simply Wall Street", based in Australia, has got this right as the %ages quoted would have required TR1s and I can't find any for them. Neither do they appear on the Avacta website.

Am I missing something?

... are closing their short, then they need to buy the shares back.

They can only do this if people are prepared to sell. If people hold then they will need to pay a higher price.

Who knows what they might have to pay if there was a surge in buys.

I agree we might see some shenanigans but the principle remains.

They certainly won't want a positive RNS on any topic.

Onwards Avacta.

Due to buy back then.

Lovely jubbly.

If you ever talk sense then post again.

Aldebaran,

If you ever talk sense the post again. Otherwise, you become another green box.

Onwards Avacta.

https://avacta.com/

Whilst I am by no means an expert, my understanding is that to short a share you borrow shares to sell and then try and buy them back at less than you sold them for in order to make a profit.

The risk is that as you buy the shares back the price goes up beyond the price that you sold at and this is the risk being taken by any shorter.

Holding and buying by existing holders is the best way to increase that risk for the shorter.

Happy to be corrected but sticking with that approach to await the sp increase when shorters have to buy back

Onwards Avacta.

uamalik,

You told us that you sold up at 73p and were waiting for a lower reentry point. Looks like that hasn't changed.

When you say that there are no inflection points for five months, does that mean that Daewong, LG Chem, Point, Moderna and others have all told you that nothing is happening?

Please clarify. Thanks.